Methods and compositions for screening for trans-acting elements in plant cells
A high-throughput method for characterizing trans-acting elements in plant cells through magnetic sorting and sequencing addresses the limitations of existing assays, facilitating the study of TFs and guiding crop improvement.
Patent Information
- Application Number
- PCT/US2026/027147
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-07
- Filing Date
- 2026-05-07
- Publication Date
- 2026-11-12
AI Technical Summary
The challenge of predicting protein function from sequence alone, particularly for transcription factors (TFs) in plants, is hindered by the lack of high-throughput methods due to the laborious and time-consuming nature of plant transformation, and existing assays like STARR-seq are limited to cis-regulatory sequences, not trans-acting elements.
A method using a library of trans-acting elements in plant cells, where each cell expresses at most one transgene, followed by magnetic sorting based on a reporter gene expression, allowing for the enrichment and sequencing of nuclei with specific activity levels, enabling parallel characterization of thousands of TFs.
Enables high-throughput study of TF regulatory activity in plants, providing data for predictive models and guiding genetic engineering efforts for crop improvement by identifying activator and repressor capacities of TFs.
Smart Images

Figure US2026027147_12112026_PF_FP_ABST
Abstract
Description
Attorney Docket: 2025-122-02 Lawrence Berkeley National LaboratoryMethods and compositions for screening for trans-acting elements in plant cells Inventors: Simon Alamos, Patrick M. ShihCROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application claims priority to U. S. Provisional Patent Application Ser. No.63 / 801,713, filed May 7, 2025, which is hereby incorporated by reference.STATEMENT OF GOVERNMENTAL SUPPORT
[0002] The invention was made with government support under Contract Nos. DE-AC02-05CH11231 awarded by the U. S. Department of Energy. The government has certain rights in the invention.REFERENCE TO SEQUENCE LISTING
[0003] The instant application contains a Sequence Listing which has been submitted electronically in XML format and is hereby incorporated by reference in its entirety. Said XML copy, created on, is named “,” and is, bytes in size.FIELD OF THE INVENTION
[0004] The present invention is in the field of screening for trans-acting elements in plant cells.BACKGROUND OF THE INVENTION
[0005] The past two decades have witnessed the accumulation of vast amounts of crop genomic data at an ever increasing pace, yet the functional annotation of this genetic variation still lags far behind. This data deluge has laid bare the persisting challenge of making sense of regulatory as well as coding DNA variants to design more resilient crop varieties (1). Indeed, predicting protein function from sequence alone remains one of the key challenges in biology as a whole. The advent of accessible machine learning models to predict protein activity has put renewed pressure on closing this gap since the accuracy of their predictions depends on large amounts of high quality annotated functional training data. Unlike other experimental systems, plant transformation is laborious and time consuming, severely limiting the throughput of characterization approaches involving transgenes. ToAttorney Docket: 2025-122-02 Lawrence Berkeley National Laboratorycircumvent this limitation, researchers have used transient reporter assays such as STARR-seq to characterize large gene libraries in parallel. However, these methods can only be used for cis-regulatory sequences like enhancers, promoters, and UTRs and not for protein-coding sequences acting in trans to the reporter.
[0006] The problem of sequence to function prediction is particularly challenging for transcription factors (TFs), a class of proteins involved in virtually all aspects of plant biology (2). The reason for this lies in the fact that a key function of many TFs - activating transcription of their target genes - is usually encoded in highly disordered domains with poor sequence conservation known as activation domains (ADs) (3-5). These features of ADs have complicated the use of structural approaches and comparative genomics to establish sequence-to-function relationships. Furthermore, mutations in ADs are well tolerated or have subtle phenotypic effects, which has conspired against the use of classic random mutagenesis screens (6). It is usually impossible to predict the boundaries of ADs within a TF based on sequence alone, not to speak of their transcriptional strength. This contrasts with other aspects of plant TF function such as DNA binding that are encoded in well-structured conserved domains and can be studied in vitro in a high throughput manner (7).
[0007] Given the limitations of traditional methods, the high throughput study of TF regulatory activity has focused on exploring the protein sequence space using massively parallel reporter assays (MPRAs) (8). Here, TF libraries are transformed into cultured cells where they drive the expression of a transcriptional reporter. Cells are then sorted according to the level of reporter expression and next-generation sequencing is used to determine the abundance of each transgene in each sorted bin, a proxy for their activity (9). This kind of assay allows not only empirically mapping ADs at a genomic scale, it also yields the breadth of data necessary to train predictive models of AD location and function (10-12). Such surrogate models provide a way to perform inference on protein sequences that are too costly or time-consuming to characterize experimentally (13). Over the last decade, reporter-based sorting MPRAs have enabled the study of TF libraries in yeast and animal cells, opening whole new avenues of inquiry and leading to a number of predictive models to predict AD position and strength (10-12,14-20). However, such assays have so far been absent in plants and, as a result, our view of plant transcriptional regulation in general and of plant TFs in particular is inherently biased from model organisms that diverged from plants > 1 billionAttorney Docket: 2025-122-02 Lawrence Berkeley National Laboratorycomprise the binding-peptide.
[0012] In some embodiments, the binding-peptide and a binding-compound form a specific binding-pair. In some embodiments, the binding-peptide is an antibody, or an antigen binding fragment thereof, and the binding-compound is an antigen, wherein the antibody, or an antigen binding fragment thereof, specifically binds the antigen. In some embodiments, the binding-peptide is a first binding-peptide and the binding-compound is a second binding-peptide, wherein the first binding-peptide specifically binds the second binding-peptide. In some embodiments, the first binding-peptide is an antibody, or an antigen binding fragment thereof, and the second binding-peptide is an antigen, wherein the antibody, or an antigen binding fragment thereof, specifically binds the antigen, or vice versa.
[0013] In some embodiments, the binding-peptide is a peptide that specifically binds a metal ion, and the binding-compound is a metal ion. In some embodiments, the binding-peptide is a polyhistidine tag, such as a polypeptide of six or more histidine residues, and the metal ion is nickel, cobalt, copper, or the like.
[0014] In some embodiments, the binding-peptide is an biotin acceptor peptide, and the method further comprises binding a biotin to the biotin acceptor peptide, wherein the biotin acceptor peptide specifically binds the biotin. In some embodiments, the binding-compound is bound to a means for separating the nuclei that comprise the binding-peptide from nuclei that do not comprise the binding-peptide. In some embodiments, the binding-compound is bound to a magnetic support, such as a magnetic bead, or a substrate, such as resin, such as a resin bead or a resin fixed to a fixed support, such as a column. In some embodiments, when the binding-peptide is bound to a biotin, the binding-compound is a streptavidin which in turn is bound to a magnetic support or substrate.
[0015] In some embodiments, the library of trans-acting elements comprises a library of variants of a fusion protein comprising an activator or repressor domain linked to a DNA binding domain. In some embodiments, the plant cell is a reporter plant cell comprising a two-part reporter gene comprising a surface marker and a fluorescent protein. In some embodiments, the two-part reporter gene is under the control of a strong promoter and capable of being activated or repressed by the fusion protein or the trans-acting element, such as a transcriptional activator or repressor domain. In some embodiments, the transforming step comprises one trans-acting element transforming about or at most one plant cell to formAttorney Docket: 2025-122-02 Lawrence Berkeley National Laboratorya transformed plant cell.
[0016] In some embodiments, the method for enriching trans-acting elements comprises: (a) providing a library of first constructs encoding a library of different trans-acting elements, wherein each first construct encodes a trans-acting element operatively linked to a promoter; (b) providing a plurality of a second construct encoding an outer nuclear envelope tag comprising a biotin acceptor peptide; (c) transforming a plurality of plant cells with the library of constructs and the plurality of second constructs, wherein one first construct transforms about one plant cell to form a transformed plant cell, and the first construct expresses a biotin acceptor peptide which is transported to a nuclear membrane of a nucleus of the transformed plant cell; (d) binding a biotin to each biotin acceptor peptide to form a biotin acceptor peptide-biotin complex; (e) isolating a plurality of nuclei from the transformed plurality of plant cells; (f) binding a streptavidin-magnetic bead to the biotin; (g) separating nuclei that comprise a biotin acceptor peptide-biotin complex bound to the streptavidin-magnetic bead from nuclei that do not comprise a biotin acceptor peptide-biotin complex bound to the streptavidin-magnetic bead using a magnetic field; (h) optionally determining, identifying, or sequencing the trans-acting elements in the isolated plurality of nuclei of step (e); (i) optionally determining, identifying, or sequencing the trans-acting elements in separated nuclei comprise a biotin acceptor peptide-biotin complex bound to the streptavidin-magnetic bead; and, (j) determining or calculating the relative fold difference each kind, type or sequence of the trans-acting elements determined, identified, or sequenced in steps (h) and step (i).
[0017] In some embodiments, the method for enriching trans-acting elements comprises: (a) providing a library of first constructs, wherein each first construct encodes a trans-acting element operatively linked to a promoter, and the library comprises a plurality of different trans-acting elements; (b) providing a plurality of second constructs, wherein each second construct encoding an outer nuclear envelope tag comprising a biotin acceptor peptide; (c) transforming a plurality of plant cells with the library of constructs and the plurality of second constructs, wherein (1) one first construct transforms about one plant cell to form a transformed plant cell, and (2) the first construct expresses a biotin acceptor peptide which is transported to a nuclear membrane of a nucleus of the transformed plant cell; (d) binding a biotin to each biotin acceptor peptide with a BirA, or an enzymatically active variant thereof, to form a biotin acceptor peptide-biotin complex; (e) isolating a plurality of nuclei from theAttorney Docket: 2025-122-02 Lawrence Berkeley National Laboratorytransformed plurality of plant cells; (f) binding a streptavidin-magnetic bead to the biotin; (g) separating nuclei that comprise a biotin acceptor peptide-biotin complex bound to the streptavidin-magnetic bead from nuclei that do not comprise a biotin acceptor peptide-biotin complex bound to the streptavidin-magnetic bead using a magnetic field; (h) optionally determining, identifying, or sequencing the trans-acting elements in the isolated plurality of nuclei of step (e); (i) optionally determining, identifying, or sequencing the trans-acting elements in separated nuclei comprise a biotin acceptor peptide-biotin complex bound to the streptavidin-magnetic bead; and, (j) determining or calculating the relative fold difference each kind, type or sequence of the trans-acting elements determined, identified, or sequenced in steps (h) and step (i).
[0018] In some embodiments, the plant cells are a whole plant or a part thereof. In some embodiments, the plant part is a leaf, stem, roots, or seed. In some embodiments, the plant cells are Nicotiana benthamiana cells. In some embodiments, the Nicotiana cells are Nicotiana benthamiana cells.
[0019] In some embodiments, the BirA, or an enzymatically active variant thereof, comprises an amino acid sequence having at least about 70%, 80%, 90%, 95%, 99%, or 100% amino acid identity with any wild-type BirA or SEQ ID NO: 1 (Escherichia coli BirA).
[0020] The present invention provides for a nucleic acid construct encoding a fusion polypeptide comprising a biotin acceptor peptide fused to an outer nuclear envelope targeting domain operatively linked to a promoter capable of expressing the fusion polypeptide in a plant cell.
[0021] The present invention provides for a composition comprising a plurality of the nucleic acid construct of the present invention, and a library of constructs, wherein each construct of the library encodes a trans-acting element operatively linked to a promoter capable of expressing the trans-acting element in the plant cell, and the library comprises a plurality of different trans-acting elements.
[0022] The present invention provides for a plurality of isolated nuclei of the method of the present invention. The present invention provides for a plurality of the nuclei that comprise the binding-peptide that are separated from the nuclei that do not comprise the binding-peptide. In some embodiments, the plurality of the nuclei that comprise the binding-peptide are bound to the binding-compound.Attorney Docket: 2025-122-02 Lawrence Berkeley National Laboratory
[0023] In some embodiments, the method comprises characterizing the regulatory activity of gene variants from a library within plant cells. In some embodiments, the method comprises measuring activity of each gene in the library.
[0024] In some embodiments, the DNA-binding domain is a DNA-binding domain of a eukaryotic transcription factor (TF) or a prokaryotic TF. In some embodiments, the DNA-binding domain is a DNA-binding domain of a eukaryotic TF. In some embodiments, the DNA-binding domain is a deactivated RNA-guided nuclease variant of Cas9 (dCas9). In some embodiments, the DNA-binding domain is about 8, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, 130, 140, 146, or 150 amino acid residues long, or within a range of any two preceding values.
[0025] In some embodiments, the eukaryotic TF is a yeast TF. In some embodiments, the yeast TF is a Saccharomyces TF. In some embodiments, the Saccharomyces TF is a Saccharomyces cerevisiae TF.
[0026] In some embodiments, the S. cerevisiae TF is Gal4, YAP1, GAT1, MATAL1, MATAL2, MCM1, Abfl, Adri, Ashl, Gcn4, Gcrl, Hap4, Hsfl, Imel, Ino2 / Ino4, Leu3, Lysl4, Mata2, Mga2, Met4, Migl, Rapl, Rgtl, Rlml, Smpl, Rmel, Roxl, Rtg3, Spt23, Teal, Ume6, or Zapl. In some embodiments, the S. cerevisiae TF is Gal4, YAP1, GAT1, MATAL1, MATAL2, orMCMl.
[0027] In some embodiments, the S. cerevisiae TF is Gal4. In some embodiments, the DNA-binding domain comprises the amino acid sequence of Gal4 or MKLLSSIEQA CDICRLKKLK CSKEKPKCAK CLKNNWECRY SPKTKRSPLT RAHLTEVESR LERLEQLFLL IFPREDLDMI LKMDSLQDIK ALLTGLFVQD NVNKDAVTDR LASVETDMPL TLRQHRISAT SSSEESSNKG QRQLTV (SEQ ID NO:4).
[0028] In some embodiments, the S. cerevisiae TF is YAP1. In some embodiments, the DNA-binding domain comprises the amino acid sequence of YAP 1, PETKQKR TAQNRAAQRA FRERKERKMK ELEKKVQSLE SIQQQNEVEA TFLRDQLITL VNELKKY (SEQ ID NO: 5) or KQ DLDPETKQKR TAQNRAAQRA FRERKERKMK ELEKKVQSLE SIQQQNEVEA TFLRDQLITL VNELKKYRPE TRNDSKVLEY LARRDPNL (SEQ ID NO: 6).
[0029] In some embodiments, the S. cerevisiae TF is GAT1. In some embodiments, theAttorney Docket: 2025-122-02 Lawrence Berkeley National LaboratoryDNA-binding domain comprises the amino acid sequence of GAT1, IFTNNLP FLNNNSINNN HSHNSSHNNN SPSIANNTNA NTNTNTSAST NTNSPLL (SEQ ID NO:7) or D DHFIFTNNLP FLNNNSINNN HSHNSSHNNN SPSIANNTNA NTNTNTSAST NTNSPLLRRN PSP (SEQ ID NO:8).
[0030] In some embodiments, the S. cerevisiae TF is MAT ALL In some embodiments, the DNA-binding domain comprises the amino acid sequence of MAT AL 1 or KKEKS PKGKSSISPQ ARAFLEQVFR RKQSLNSKEK EEVAKKCGIT PLQVRVWFIN KRMRSK(SEQ ID NO:9).
[0031] In some embodiments, the S. cerevisiae TF is MATAL2. In some embodiments, the DNA-binding domain comprises the amino acid sequence of MATAL2 or STKP YRGHRFTKEN VRILESWFAK NIENPYLDTK GLENLMKNTS LSRIQIKNWV SNRRRKEKTI TIAP (SEQ ID NO: 10).
[0032] In some embodiments, the S. cerevisiae TF is MCM1. In some embodiments, the DNA-binding domain comprises the amino acid sequence of MCM1, RRK IEIKFIENKT RRHVTFSKRK HGIMKKAFEL SVLTGTQVLL LVVSETGLVY TF (SEQ ID NO: 11) or KERRK IEIKFIENKT RRHVTFSKRK HGIMKKAFEL SVLTGTQVLL LVVSETGLVY TFSTPKFEPI VTQQEGRNLI QACLNA (SEQ ID NO: 12).
[0033] In some embodiments, the S. cerevisiae TF is Rapl. In some embodiments, the DNA-binding domain comprises the amino acid sequence of Rapl, or GXXIRXRF (wherein X is any amino acid) (SEQ ID NO: 13), GGSIRXRF (wherein X is any amino acid) (SEQ ID NO: 14), GPSIRXRF (wherein X is any amino acid) (SEQ ID NO: 15), GASIRXRF (wherein X is any amino acid) (SEQ ID NO: 16), GRSIRXRF (wherein X is any amino acid) (SEQ ID NO: 17), GGAIRXRF (wherein X is any amino acid) (SEQ ID NO: 18), GPAIRXRF (wherein X is any amino acid) (SEQ ID NO: 19), GAAIRXRF (wherein X is any amino acid) (SEQ ID NO:20), GRAIRXRF (wherein X is any amino acid) (SEQ ID NO:21), or GNSIRHRFRV(SEQ ID NO:22).
[0034] In some embodiments, wherein any two, or all, of the DNA-binding domain is heterologous to the trans-acting element or activator domain. In some embodiments, wherein one or more, or all, of the DNA-binding domain and / or trans-acting element or activator domain are obtained or derived from a non-viral organism.Attorney Docket: 2025-122-02 Lawrence Berkeley National Laboratory
[0035] In some embodiments, the DNA-binding domain and the trans-acting element or activator domain are linked in this order from N- to C-terminus.
[0036] The present invention also provides for a host cell comprising any construct of the present invention, wherein the host cell is capable of stably maintaining the construct.
[0037] In some embodiments, the DNA-binding domain and the trans-acting element or activator domain are heterologous to the plant cell or plant, and / or any of the promoters.
[0038] Escherichia coli BirA is a bifunctional ligase / repressor. In the presence of ATP, BirA activates biotin to form the BirA-biotinyl-5'-adenylate (BirA-bio-5'-AMP or holoBirA) complex. HoloBirA can either transfer the biotinyl moiety to the biotin carboxyl carrier protein (BCCP) subunit of acetyl-CoA carboxylase.
[0039] E. coli BirA has the following amino acid sequence:********* 'k'k'k'k'k'k'k'k'k'k 'kMKDNTVPLKL IALLANGEFH SGEQLGETLG MSRAAINKHI QTLRDWGVDV FTVPGKGYSL PEPIQLLNAK QILGQLDGGS VAVLPVIDST NQYLLDRIGE LKSGDACIAE YQQAGRGRRG RKWFSPFGAN LYLSMFWRLE QGPAAAIGLS*LVIGIVMAEV LRKLGADKVR VKWPNDLYLQ DRKLAGILVE LTGKTGDAAQ IVIGAGINMA MRRVEESVVN QGWITLQEAG INLDRNTLAA MLIRELRAAL ELFEQEGLAP YLSRWEKLDN FINRPVKLII GDKEIFGISR GIDKQGALLL EQDGIIKPWM GGEISLRSAE K (SEQ ID NO: 1)
[0040] In some embodiments, the BirA, or an enzymatically active variant thereof, comprises the amino acid residues at positions 22-41 (SEQ ID NO:2), 89-91, 112, 116-118, and / or 183 corresponding to SEQ ID NO: 1. The amino acid residues at positions 22-41 comprise a H-T-I I motif and form the DNA-binding of the BPL / LPL catalytic domain, and the amino acid residues at positions 112, 116-118, and 183 form binding sites of biotin of the BPL / LPL catalytic domain. The amino acid residues at positions 22-41 of SEQ ID NO:1 have the following amino acid sequence: GEQLGETLG MSRAAINKHI Q (SEQ ID NO:2).
[0041] In some embodiments, the BirA, or an enzymatically active variant thereof, comprises SEQ ID NO:3, or the amino acids at positions 67-254 of SEQ ID NO: 1, which forms theAttorney Docket: 2025-122-02 Lawrence Berkeley National LaboratoryBPL / LPL catalytic domain. The amino acids at positions 67-254 of SEQ ID NO: 1 have the following amino acid sequence. LNAK QILGQLDGGS VAVLPVIDST NQYLLDRIGE LKSGDACIAE YQQAGRGRRG RKWFSPFGAN LYLSMFWRLE QGPAAAIGLS LVIGIVMAEV LRKLGADKVR VKWPNDLYLQ DRKLAGILVE LTGKTGDAAQ IVIGAGINMA MRRVEESVVN QGWITLQEAG INLDRNTLAA MLIRELRAAL ELFE(SEQ ID NO:3).
[0042] The present invention provides for a platform or method to characterize the activity of large libraries (such as in the order of thousands) gene regulatory sequences in plant cells, in parallel. In some embodiments, the platform or method comprises the following: (1) expressing transgene libraries in plant leaves, such as the leaves of Nicotiana benthamiana, in a way that ensures that each plant cell expresses at most one transgene; (2) separating or sorting nuclei from these cells based on the level of expression of a reporter gene that is in turn regulated by the library transgenes; and / or, (3) sequencing the separated or sorted nuclei to determine the degree to which transgenes in the library activate or repress gene expression.
[0043] Plant genomes code for transcription factors (TFs), a class of proteins that regulate gene expression and, in doing so, modulate a myriad of phenotypes of industrial and agronomic interest. In some embodiments, a goal of the platform or method is to determine the molecular basis of TF activity, (or what parts of TFs are necessary for their activity), and / or how is this activity encoded at the sequence level (or how is the activity defined as the strength of regulation and whether they activate or repress gene expression). Currently methods for answering these questions requires testing TFs, or variants thereof, one by one, which is costly and time consuming. Some methods to rapidly study plant TFs use microorganisms, but the activity of TFs in a microorganisms does not adequately represent its role inside of a plant. In contrast, the present invention can do this simultaneously for thousands of TFs within plant cells. In some embodiments, the platform or method comprises one or more of the following: (1) Using Agrobacterium gene libraries encoding the TFs are delivered to leaf cells of N. benthamiana (tobacco) where they regulate the expression of a reporter transgene. (2) The reporter codes for a tag that, if expressed at a sufficiently high level, allows for purifying the cell nuclei using magnetic beads. (3) By purifying nuclei from tobacco expressing these libraries, samples are obtained that are enriched for TFs that activate the reporter and that therefore have activator capacity. (4) The degree of enrichment correlates with their activator strength. (5) In the case of repressors they are depleted from theAttorney Docket: 2025-122-02 Lawrence Berkeley National Laboratorymagnetically purified nuclei. (6) An engineered nuclear purification tag. (7) Delivery of the TF libraries into plant leaves, (8) The level of expression of the tag reflects the strength of the TF driving its expression. (9) Cloning and constructing, and / or delivering large gene libraries into plant cells. (10) Each cell expresses at most one TF.
[0044] This platform can be used to find out whether a protein is capable of regulating plant gene expression. It can also be used to determine what parts of a protein can regulate gene expression in a plant cell. It is also applicable to screening engineered and natural variants of a protein of interest to find versions with altered activities. This output can be used to guide genetic engineering efforts of optimized crop varieties.BRIEF DESCRIPTION OF THE DRAWINGS
[0045] The foregoing aspects and others will be readily appreciated by the skilled artisan from the following description of illustrative embodiments when read in conjunction with the accompanying drawings.
[0046] Figure 1: Design and optimization of an assay to measure the activity of transacting elements in parallel in plant cells. (A) Overview of the ENTRAP-seq assay. A library of n different trans-acting elements such as transcription factors (TFs) of varying strengths is cloned in binary vectors for AgroZ>actera / m-mediated transformation. These trans elements regulate a promoter driving the expression of an outer nuclear envelope tag (ONEtag) containing a biotin acceptor peptide. A transgene for the constitutive expression of the biotin ligase BirA is also included to biotinylate the ONEtag. The library as well as the ONEtag reporter and BirA are transformed into Agrobacterium and mixed cultures are infiltrated into leaves of N. benthamiana. The ONEtag which is then biotinylated by constitutively expressed BirA using endogenous biotin. Next, nuclei are isolated from infiltrated leaves and incubated with magnetic streptavidin-coated beads, allowing magnetic sorting. DNA is extracted from the unsorted and sorted nuclei samples and the abundance of each of the trans-elements in the library in (A) is determined by sequencing the T-DNA. The enrichment of a given trans element in the sorted vs unsorted population correlates with its activation strength. (B) Live cell fluorescence microscopy images of N. benthamiana epidermis cells expressing a nuclear marker (H2B-RFP) and different ONEtag candidate versions fused to GFP. Bar = 20 um. A schematic of each ONEtag construct tested is shown on top of the corresponding images. (C) Schematic of the construct used in (D) and (E) toAttorney Docket: 2025-122-02 Lawrence Berkeley National Laboratorycompare promoter activity (RFP fluorescence) with ONEtag accumulation (GFP fluorescence). (D) Scatter plot showing RFP (x axis) and GFP (y axis) fluorescence of leaf punches expressing the construct in (C) containing the S1WIP1-C ONEtag combined with a second strain carrying Gal4DBD or Gal4-VP16. (E) Same as (D) for a ONEtag containing S1WIP2-C. (F) Schematic of the experiment to test the sensitivity of the S1WIP2-C ONE tag. Gal4DBD fusions to effector domains of Arabidopsis TFs of varying strengths were used to drive the expression of the reporter. (G) Scatter plot of the GFP (x axis) and RFP (y axis) fluorescence expressing the constructs in (F). In (D), (E), and (G) N = 24 (3 plants with 8 leaf punches per plant).
[0047] Figure 2: Assay validation comparing pooled sequencing with single-infiltration reporter fluorescence. (A) T-DNA constructs used to validate the parallel reporter assay. A synthetic promoter containing 6x Gal4 UAS sites followed by the minimal 35S promoter is used to drive the ONEtag fused to RFP by a self-cleaving T2A peptide. Downstream of the ONEtag, the plasmid contains a BirA expression cassette and a constitutively-expressed fusion between the Gal4 DBD and variable 53 aa tiles of various strengths. (B) Experimental strategy. Left: strains carrying the 26 constructs from (A) are grown separately and mixed in equal OD ratios prior to leaf infiltration at a final total OD of 0.0025. ENTRAP-seq is then used to determine the activation strength of each tile based on its enrichment in the pulldown fraction. Right: each of the strains in (A) is infiltrated individually at an OD of 0.2. The activity of each tile is determined by measuring the RFP fluorescence of infiltrated leaves in a plate reader. (C) Y-axis: Tile transcriptional activity measured individually using a fluorescence plate reader. X-axis: transcriptional activity of each tile based on ENTRAP-seq (enrichment of each tile T-DNA in the nuclei pulldown fraction compared to the flow-through sample). N for nuclei pulldown and sequencing = 4 biological replicates. N for plate reader assays = 24 (3 plants with 8 leaf punches per plant), p = Spearman’s correlation coefficient.
[0048] Figure 3: Generation of nested libraries of putative viral activation domains to test assay scale and reproducibility. (A) Schematic of the computational pipeline to generate libraries of putative transcriptional activation domains from plant viruses. From the top: protein ORF sequences from genomes of all plant viruses in NCBI were deduplicated and clustered using 90% sequence identity then fragmented into 53 aa tiles with 10 bp overlap. PADDLE was used to predict the transactivation strength of these tiles. The topAttorney Docket: 2025-122-02 Lawrence Berkeley National Laboratory2,000 tiles with the highest predicted activity were selected (PADDLE Z-score > 5). Protein sequences were binary encoded, and sequence diversity maximization algorithm was applied to iteratively select sequences that maximized the average Hamming distance from those already included in the subset. This approach enriched for sequence-level diversity in the selected proteins to generate nested libraries of 250, 500, IK, and 2K tiles. (B) Tile activity as measured by ENTRAP-seq (x axis) plotted against the mean ± s.d tile activity measured individually using a fluorescence reporter assay (y axis) for two biological replicates of a library of 250, 500, IK, and 2K viral tiles. Blue lines show a sigmoidal fit to the data with the s.d of the fit shown as a shaded blue area. Horizontal dashed lines indicate the middle point of the sigmoid fits. Vertical dashed lines indicate the enrichment value corresponding to the midpoint + 1 sd. This value was taken as the lower bound of enrichment to classify tiles as activators. (C) Reproducibility between biological replicates (Pearson correlation in enrichment, y axis) as a function of the absolute number of tiles that pass a threshold number of mapped reads (x axis). The set of tiles counted on the x axis was generated by imposing coverage cutoffs such that only tiles with more counts than an arbitrary and variable threshold (color bar) were considered to calculate the Pearson correlation. (D) Reproducibility across different libraries. The activity of each tile was first averaged across both biological replicates of each library of a given size. Scatter plots show the activity of tiles that are shared between libraries of different sizes. The Pearson correlation (r) between libraries is shown.
[0049] Figure 4: Conserved and potent transcriptional activation domains are found in diverse proteins across plant virus taxa. (G) Selected strong activator viral tiles tested individually in N. benthamiana using a Gal4DBD recruitment fluorescence reporter assay. Shown is the normalized GFP fluorescence (Materials and Methods). (H) A set of tiles tested in (G) were recruited to a synthetic reporter driving GFP using dCas9. Shown is the normalized leaf GFP fluorescence. In (G) and (H) brackets indicate two-sided t-test comparisons against VP 16 with a Bonferroni multiple comparison correction. * p < 0.05, ** p < 0.01, *** p < 0.001, ns not significant. In (G) and (H) box plots show the median ± IQR, bars correspond to minimum and maximum values excluding outliers.
[0050] Figure 5: Systematic comparison of tiles from Arabidopsis TFs expressed in yeast and N. benthamiana. (A) Comparison of tile transcriptional activity between yeast and N. benthamiana. A set of peptide tiles from Arabidopsis TFs previously measured in yeast was tested in N. benthamiana. Scatterplot shows the activity of each tile in yeast (PADI score, yAttorney Docket: 2025-122-02 Lawrence Berkeley National Laboratoryaxis) and N. benthamiana (tile enrichment, x axis). Histograms show the distribution of tile activities on each axis. (B) Activity of a subset of tiles from (A) measured individually using a fluorescence reporter assay (y axis) plotted against their activity based on sequencing (x-axis). The amino acid sequence shown is SEQ ID NO:23. (C) The degree of structural disorder of each tile is plotted against its activity based on sequencing in N. benthamiana. The histogram on the right includes tiles considered as activators in both yeast and N. benthamiana and N. benthamiana only. The amino acid sequence shown is SEQ ID NO:24.(D) ADs identified in the Arabidopsis ARE 19 TF in yeast (orange rectangles) and N. benthamiana (blue rectangle). Highlighted in red is the ARF19 middle region containing a glutamine rich activation domain. (E) Examples of Arabidopsis TFs for which ADs were found in both yeast and N. benthamiana assays but these ADs fall on different parts of the protein. (F) Examples of TFs that had no identified AD in yeast that were found to have an AD in N. benthamiana.
[0051] Figure 6: Large scale screening of mutant activation domains to create an allelic series of the CO transcription factor. (A) Transactivation assay for CO function in N. benthamiana. A strain carrying GFP driven by the Arabidopsis FT promoter (proFT) was infiltrated with a strain carrying pUBQ-BFP-CO or an empty vector (EV). pUBQ-mCherry was used as a normalization. Box plot shows the mean +- interquartile range, whiskers are minimum and maximum values. Shown p is from a two-sided t-test. (B) Location of the CO activation domain (AD). Plot shows the probability of residues being part of an acidic AD according to the ADpred software. Bars on top show the empirically determined AD. The blue box indicates the 69 aa region used to build a tile library. (C) Screening of CO the AD tile library using nuclei enrichment. Mutant tiles are fused to the Gal4 DBD and used to drive the expression of the magnetic sorting reporter. (D) Distribution of tile enrichment values. The dashed line shows the mean enrichment of 6 wt tiles. (E) Tile activity as a function of biochemical properties. Each dot corresponds to one tile. The dashed red lines are linear fits. Shown on top is the correlation coefficient (R2) and the p-value of the linear regression. The amino acid sequence shown is SEQ ID NO:25. (F) Heatmap showing the activity of tiles carrying single aa substitutions. (G) Transactivation assay to test the effect of mutations in the CO AD in the context of the full-length protein. Mutations identified in (C)-(F) as being weaker (loss-of-function) or stronger (gain-of-function) than the wt AD were introduced into the CO coding sequence and used to drive expression of a proFT GFP reporter. (H) FT promoter activity in the presence of various CO mutant alleles. Predicted activity is based onAttorney Docket: 2025-122-02 Lawrence Berkeley National Laboratorythe enrichment of the corresponding AD tile with respect to the wt tile. Box plots show the median ± IQR, bars correspond to minimum and maximum values excluding outliers.. *** p < 0.001, ** p < 0.01, * p < 0.05, n.s not significantly different using a t-test against wt with a Bonferroni multiple comparison correction.
[0052] Figure 7: Additional ONEtag optimization details.
[0053] Figure 8: Efficiency of nucleus pulldown.
[0054] Figure 9: No correlation between tile coverage in the library and its enrichment ratio.
[0055] Figure 10: Strong activator tiles from plant viruses.
[0056] Figure 11: PADDLE and TAD A.
[0057] Figure 12: Biochemical properties of the CO acidic AD.
[0058] Figure 13: Replicate of CO alleles regulating the FT promoter driving GFP.DETAILED DESCRIPTION OF THE INVENTION
[0059] Before the invention is described in detail, it is to be understood that, unless otherwise indicated, this invention is not limited to particular sequences, expression vectors, enzymes, host microorganisms, or processes, as such may vary. It is also to be understood that the terminology used herein is for purposes of describing particular embodiments only, and is not intended to be limiting.
[0060] In this specification and in the claims that follow, reference will be made to a number of terms that shall be defined to have the following meanings:
[0061] The terms "optional" or "optionally" as used herein mean that the subsequently described feature or structure may or may not be present, or that the subsequently described event or circumstance may or may not occur, and that the description includes instances where a particular feature or structure is present and instances where the feature or structure is absent, or instances where the event or circumstance occurs and instances where it does not.
[0062] Where a range of values is provided, it is understood that each intervening value, to the tenth of the unit of the lower limit unless the context clearly dictates otherwise, betweenAttorney Docket: 2025-122-02 Lawrence Berkeley National Laboratorythe upper and lower limits of that range is also specifically disclosed. Each smaller range between any stated value or intervening value in a stated range and any other stated or intervening value in that stated range is encompassed within the invention. The upper and lower limits of these smaller ranges may independently be included or excluded in the range, and each range where either, neither or both limits are included in the smaller ranges is also encompassed within the invention, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included in the invention.
[0063] The term “about” refers to a value including 10% more than the stated value and 10% less than the stated value.
[0064] As used herein, the term "promoter" refers to a polynucleotide sequence capable of driving transcription of a DNA sequence in a cell. Thus, promoters used in the polynucleotide constructs of the invention include cis- and trans-acting transcriptional control elements and regulatory sequences that are involved in regulating or modulating the timing and / or rate of transcription of a gene. For example, a promoter can be a cis-acting transcriptional control element, including an enhancer, a promoter, a transcription terminator, an origin of replication, a chromosomal integration sequence, 5' and 3' untranslated regions, or an intronic sequence, which are involved in transcriptional regulation. These cis-acting sequences typically interact with proteins or other biomolecules to carry out (turn on / off, regulate, modulate, etc.) gene transcription. Promoters are located 5' to the transcribed gene, and as used herein, include the sequence 5' from the translation start codon.
[0065] A "constitutive promoter" is one that is capable of initiating transcription in nearly all cell types, whereas a "cell type-specific promoter" initiates transcription only in one or a few particular cell types or groups of cells forming a tissue. In some embodiments, the promoter is secondary cell wall-specific and / or fiber cell-specific. A "fiber cell-specific promoter" refers to a promoter that initiates substantially higher levels of transcription in fiber cells as compared to other non-fiber cells of the plant. A "secondary cell wall-specific promoter" refers to a promoter that initiates substantially higher levels of transcription in cell types that have secondary cell walls, e.g., lignified tissues such as vessels and fibers, which may be found in wood and bark cells of a tree, as well as other parts of plants such as the leaf stalk. In some embodiments, a promoter is fiber cell-specific or secondary cell wall-specific if the transcription levels initiated by the promoter in fiber cells or secondary cell walls,Attorney Docket: 2025-122-02 Lawrence Berkeley National Laboratoryrespectively, are at least 3-fold, 4-fold, 5-fold, 6-fold, 7-fold, 8-fold, 9-fold, 10-fold, 50-fold, 100-fold, 500-fold, 000-fold higher or more as compared to the transcription levels initiated by the promoter in other tissues, resulting in the encoded protein substantially localized in plant cells that possess fiber cells or secondary cell wall, e.g, the stem of a plant. Nonlimiting examples of fiber cell and / or secondary cell wall specific promoters include the promoters directing expression of the genes IRX1, IRX3, IRX5, IRX7, IRX8, IRX9, IRX10, IRX14, NST1, NST2, NST3, MYB46, MYB58, MYB63, MYB83, MYB85, MYB103, PALI, PAL2, C3H, CcOAMT, CCR1, F5H, LAC4, LAC17, CADc, and CADd. See, e.g. Turner et al 1997; Meyer et al 1998; Jones et al 2001; Franke et al 2002; Ha et al 2002; Rohde et al 2004; Chen et al 2005; Stobout et al 2005; Brown et al 2005; Mitsuda et al 2005; Zhong et al 2006; Mitsuda et al 2007; Zhong et al 2007a, 2007b; Zhou et al 2009; Brown et al 2009; McCarthy et al 2009; Ko et al 2009; Wu et al 2010; Berthet et al 2011. In some embodiments, a promoter is substantially identical to a promoter from the lignin biosynthesis pathway. A promoter originated from one plant species may be used to direct gene expression in another plant species.
[0066] A polynucleotide or amino acid sequence is "heterologous" to an organism or a second polynucleotide or amino acid sequence if it originates from a foreign species, or, if from the same species, is modified from its original form. For example, when a polynucleotide encoding a polypeptide sequence is said to be operably linked to a heterologous promoter, it means that the polynucleotide coding sequence encoding the polypeptide is derived from one species whereas the promoter sequence is derived from another, different species; or, if both are derived from the same species, the coding sequence is not naturally associated with the promoter (e.g., is a genetically engineered coding sequence, e.g., from a different gene in the same species, or an allele from a different ecotype or variety, or a gene that is not naturally expressed in the target tissue).
[0067] The term "operably linked" refers to a functional relationship between two or more polynucleotide (e.g., DNA) segments. Typically, it refers to the functional relationship of a transcriptional regulatory sequence to a transcribed sequence. For example, a promoter or enhancer sequence is operably linked to a DNA or RNA sequence if it stimulates or modulates the transcription of the DNA or RNA sequence in an appropriate host cell or other expression system. Generally, promoter transcriptional regulatory sequences that are operably linked to a transcribed sequence are physically contiguous to the transcribed sequence, i.e.Attorney Docket: 2025-122-02 Lawrence Berkeley National Laboratorythey are cis-acting. However, some transcriptional regulatory sequences, such as enhancers, need not be physically contiguous or located in close proximity to the coding sequences whose transcription they enhance.
[0068] The terms “host cell” of “host organism” is used herein to refer to a living biological cell that can be transformed via insertion of an expression vector.
[0069] The terms "expression vector" or "vector" refer to a compound and / or composition that transduces, transforms, or infects a host cell, thereby causing the cell to express nucleic acids and / or proteins other than those native to the cell, or in a manner not native to the cell. An "expression vector" contains a sequence of nucleic acids (ordinarily RNA or DNA) to be expressed by the host cell. Optionally, the expression vector also comprises materials to aid in achieving entry of the nucleic acid into the host cell, such as a virus, liposome, protein coating, or the like. The expression vectors contemplated for use in the present invention include those into which a nucleic acid sequence can be inserted, along with any preferred or required operational elements. Further, the expression vector must be one that can be transferred into a host cell and replicated therein. Particular expression vectors are plasmids, particularly those with restriction sites that have been well documented and that contain the operational elements preferred or required for transcription of the nucleic acid sequence. Such plasmids, as well as other expression vectors, are well known to those of ordinary skill in the art.
[0070] The terms "polynucleotide" and "nucleic acid" are used interchangeably and refer to a single or double-stranded polymer of deoxyribonucleotide or ribonucleotide bases read from the 5' to the 3' end. A nucleic acid of the present invention will generally contain phosphodiester bonds, although in some cases, nucleic acid analogs may be used that may have alternate backbones, comprising, e.g., phosphoramidate, phosphorothioate, phosphorodithioate, or O-methylphophoroamidite linkages (see Eckstein, Oligonucleotides and Analogues: A Practical Approach, Oxford University Press); positive backbones; nonionic backbones, and non-ribose backbones. Thus, nucleic acids or polynucleotides may also include modified nucleotides that permit correct read-through by a polymerase." Polynucleotide sequence" or "nucleic acid sequence" includes both the sense and antisense strands of a nucleic acid as either individual single strands or in a duplex. As will be appreciated by those in the art, the depiction of a single strand also defines the sequence of the complementary strand; thus the sequences described herein also provide the complementAttorney Docket: 2025-122-02 Lawrence Berkeley National Laboratoryof the sequence. Unless otherwise indicated, a particular nucleic acid sequence also implicitly encompasses variants thereof (e.g., degenerate codon substitutions) and complementary sequences, as well as the sequence explicitly indicated. The nucleic acid may be DNA, both genomic and cDNA, RNA or a hybrid, where the nucleic acid may contain combinations of deoxyribo- and ribo-nucleotides, and combinations of bases, including uracil, adenine, thymine, cytosine, guanine, inosine, xanthine hypoxanthine, isocytosine, isoguanine, etc.
[0071] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, the preferred methods and materials are now described. All publications mentioned herein are incorporated herein by reference to disclose and describe the methods and / or materials in connection with which the publications are cited.
[0072] In some embodiments, the TF can be used in the invention taught in PCT International Patent Application No. PCT / US2018 / 050514 (Publication No. WO 2019 / 051503 A2), which is hereby incorporated by reference.
[0073] In some embodiments, the DNA-binding domain is a DNA-binding domain of a eukaryotic TF or a prokaryotic TF. In some embodiments, the DNA-binding domain is a DNA-binding domain of a eukaryotic TF.
[0074] In some embodiments, the eukaryotic TF is a yeast TF. In some embodiments, the yeast TF is a Saccharomyces TF. In some embodiments, the Saccharomyces TF is a Saccharomyces cerevisiae TF. In some embodiments, the S. cerevisiae TF is Gal4, YAP1, GAT1, MATAL1, MATAL2, MCM1, Abfl, Adri, Ashl, Gcn4, Gcrl, Hap4, Hsfl, Imel, Ino2 / Ino4, Leu3, Lysl4, Mata2, Mga2, Met4, Migl, Rapl, Rgtl, Rlml, Smpl, Rmel, Roxl, Rtg3, Spt23, Teal, Ume6, or Zapl. In some embodiments, the S. cerevisiae TF is Gal4, YAP1, GAT1, MATAL1, MATAL2, MCM1, or Rapl.
[0075] In some embodiments, the activator domain is a herpes simplex virus VP 16, maize Cl, or a yeast activator domain. In some embodiments, the yeast activator domain is aAttorney Docket: 2025-122-02 Lawrence Berkeley National LaboratorySaccharomyces activator domain. In some embodiments, the Saccharomyces activator domain is a Saccharomyces cerevisiae activator domain.
[0076] In some embodiments, the S. cerevisiae activator domain is a Gal4, YAP1, GAT1, MATAL1, MATAL2, MCM1, Abfl, Adri, Ashl, Gcn4, Gcrl, Hap4, Hsfl, Imel, Ino2 / Ino4, Leu3, Lysl4, Mga2, Met4, Rapl, Rlml, Smpl, Rtg3, Spt23, Teal, Ume6, or Zapl activator domain.
[0077] In some embodiments, the promoter is a tissue-specific or inducible promoter. In some embodiments, the promoter comprises one or more DNA-binding sites specific for the transcription activator. In some embodiments, the promoter comprises 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 DNA-binding sites specific for the transcription activator).
[0078] References cited:1. Borowsky AT, Bailey-Serres J. Rewiring gene circuitry for plant improvement. Nat Genet. 2024 Aug; 56(8): 1574-82.2. Gonzalez DH. Plant Transcription Factors: Evolutionary, Structural and Functional Aspects. 1st ed. Amsterdam: Academic Press; 2015.3. Udupa A, Kotha SR, Staller MV. Commonly asked questions about transcriptional activation domains. Curr Opin Struct Biol. 2024 Feb;84: 102732.4. Soto LF, Li Z, Santoso CS, Berenson A, Ho I, Shen VX, et al. Compendium of human transcription factor effector domains. Mol Cell. 2022 Feb 3;82(3):514-26.5. Ferrie JJ, Karr JP, Tjian R, Darzacq X. “Structure” -function relationships in eukaryotic transcription factors: The role of intrinsically disordered regions in gene regulation. Mol Cell. 2022 Nov 3;82(21):3970-84.6. Staller MV, Holehouse AS, Swain-Lenz D, Das RK, Pappu RV, Cohen BA. A High-Throughput Mutational Scan of an Intrinsically Disordered Acidic Transcriptional Activation Domain. Cell Syst. 2018 Apr 25;6(4):444-455.e6.7. O’Malley RC, Huang S-SC, Song L, Lewsey MG, Bartlett A, Nery JR, et al. Cistrome and epicistrome features shape the regulatory DNA landscape. Cell. 2016 May 19;165(5):1280-92.Attorney Docket: 2025-122-02 Lawrence Berkeley National Laboratory8. Kinney JB, McCandlish DM. Massively Parallel Assays and Quantitative Sequence-Function Relationships. Annu Rev Genomics Hum Genet. 2019 Aug 31;20:99-127.9. Kinney JB, Murugan A, Callan CG, Cox EC. Using deep sequencing to characterize the biophysical mechanism of a transcriptional regulatory sequence. Proc Natl Acad Sci USA. 2010 May 18;107(20):9158-63.10. Erijman A, Kozlowski L, Sohrabi-Jahromi S, Fishburn J, Warfield L, Schreiber J, et al. A High-Throughput Screen for Transcription Activation Domains Reveals Their Sequence Features and Permits Prediction by Deep Learning. Mol Cell. 2020 Jun 4;78(5):890-902.e6.11. Sanborn AL, Yeh BT, Feigerle JT, Hao CV, Townshend RJ, Lieberman Aiden E, et al. Simple biochemical features underlie transcriptional activation domain diversity and dynamic, fuzzy binding to Mediator. eLife. 2021 Apr 27; 10.12. Morffy N, Van den Broeck L, Miller C, Emenecker RJ, Bryant JA, Lee TM, et al. Identification of plant transcriptional activation domains. Nature. 2024 Aug;632(8023):166-73.13. Hie BL, Yang KK. Adaptive machine learning for protein engineering. Curr Opin Struct Biol. 2022 Feb;72: 145-52.14. Arnold CD, Nemcko F, Woodfin AR, Wienerroither S, Vlasova A, Schleiffer A, et al. A high-throughput method to identify trans-activation domains within transcription factor sequences. EMBO J. 2018 Aug 15;37(16).15. Ravarani CN, Erkina TY, De Baets G, Dudman DC, Erkine AM, Babu MM. High-throughput discovery of functional disordered regions: investigation of transactivation domains. Mol SystBiol. 2018 May 14;14(5):e8190.16. Hummel NFC, Markel K, Stefani J, Staller MV, Shih PM. Systematic identification of transcriptional activation domains from non-transcription factor proteins in plants and yeast. Cell Syst. 2024 Jul 17;15(7):662-672.e4.17. Tycko J, DelRosso N, Hess GT, Aradhana, Banerjee A, Mukund A, et al. High-Throughput Discovery and Characterization of Human Transcriptional Effectors. Cell. 2020 Dec 23;183(7):2020-2035.el6.Attorney Docket: 2025-122-02 Lawrence Berkeley National Laboratory18. DelRosso N, Tycko J, Suzuki P, Andrews C, Aradhana, Mukund A, et al. Large-scale mapping and mutagenesis of human transcriptional effector domains. Nature. 2023 Apr 5;616(7956):365-72.19. Ludwig CH, Thurm AR, Morgens DW, Yang KJ, Tycko J, Bassik MC, et al. High-throughput discovery and characterization of viral transcriptional effectors in human cells. Cell Syst. 2023 Jun 21;14(6):482-500.e8.20. Alcantar MA, English MA, Valeri JA, Collins JJ. A high-throughput synthetic biology approach for studying combinatorial chromatin-based transcriptional regulation. Mol Cell. 2024 Jun 20;84(12):2382-2396.e9.21. Voichek Y, Hristova G, Molla-Morales A, Weigel D, Nordborg M. Widespread position-dependent transcriptional regulatory sequences in plants. Nat Genet. 2024Oct; 56(10): 2238-46.22. Arndell T, Chen J, Sperschneider J, Upadhyaya NM, Blundell C, Niesner N, et al. Pooled effector library screening in protoplasts rapidly identifies novel Avr genes. Nat Plants.2024 Apr; 10(4):572-80.23. Carlson ED, Rajniak J, Sattely ES. Multiplicity of the Agrobacterium Infection of Nicotiana benthamiana for Transient DNA Delivery. ACS Synth Biol. 2023 Aug 18;12(8):2329-38.24. Wang D, Deal RB. Epigenome profiling of specific plant cell types using a streamlined INTACT protocol and ChlP-seq. Methods Mol Biol. 2015;1284:3-25.25. Reynoso MA, Pauluzzi GC, Kajala K, Cabanlit S, Velasco J, Bazin J, et al. Nuclear transcriptomes at high resolution using retooled INTACT. Plant Physiol. 2018 Jan;176(l):270-81.26. Zhou X, Graumann K, Meier I. The plant nuclear envelope as a multifunctional platform LINCed by SUN and KASH. J Exp Bot. 2015 Mar 4;66(6): 1649-59.27. Hummel NFC, Zhou A, Li B, Markel K, Ornelas IJ, Shih PM. The trans-regulatory landscape of gene networks in plants. Cell Syst. 2023 Jun 21; 14(6):501-51 Le4.28. Deal RB, Henikoff S. The INTACT method for cell type-specific gene expression andAttorney Docket: 2025-122-02 Lawrence Berkeley National Laboratorychromatin profiling in Arabidopsis thaliana. Nat Protoc. 2011 Jan;6(l):56-68.29. Belcher MS, Vuu KM, Zhou A, Mansoori N, Agosto Ramos A, Thompson MG, et al. Design of orthogonal regulatory systems for modulating gene expression in plants. Nat Chem Biol. 2020 Aug;16(8):857-65.30. Tehrani N, Mitra RM. Plant pathogens and symbionts target the plant nucleus. Curr Opin Microbiol. 2023 Apr;72: 102284.31. Boch J, Bonas U, Lahaye T. TAL effectors— pathogen strategies and plant resistance engineering. New Phytol. 2014 Dec;204(4):823-32.32. Ray S, Casteel CL. Effector-mediated plant-virus-vector interactions. Plant Cell. 2022 Apr 26;34(5): 1514-31.33. Mauck KE, Chesnais Q, Shapiro LR. Evolutionary determinants of host and vector manipulation by plant viruses. Adv Virus Res. 2018 May 7; 101: 189-250.34. Hull R. Plant Virology. 5th ed. Amsterdam: Academic Press; 2013.35. Guerrero J, Regedanz E, Lu L, Ruan J, Bisaro DM, Sunter G. Manipulation of the plant host by the geminivirus AC2 / C2 protein, a central player in the infection cycle. Front Plant Sci. 2020 May 19; 11:591.36. Wang L, Lozano-Duran R. Manipulation of plant RNA biology by gemini viruses. J Exp Bot. 2023 Apr 9;74(7):2311-22.37. Hartitz MD, Sunter G, Bisaro DM. The tomato golden mosaic virus transactivator (TrAP) is a single-stranded DNA and zinc-binding phosphoprotein with an acidic activation domain. Virology. 1999 Oct 10;263(l): 1- 14.38. Chavez A, Scheiman J, Vora S, Pruitt BW, Tuttle M, P R Iyer E, et al. Highly efficient Cas9-mediated transcriptional programming. Nat Methods. 2015 Apr; 12(4): 326-8.39. Zinselmeier MH, Casas-Mollano JA, Cors J, Sychla A, Heinsch SC, Voytas DF, et al. Optimized dCas9 programmable transcriptional activators for plants. Plant Biotechnol J. 2024 Nov;22(ll):3202-4.40. Ulmasov T, Hagen G, Guilfoyle TJ. Activation and repression of transcription byAttorney Docket: 2025-122-02 Lawrence Berkeley National Laboratoryauxin-response factors. Proc Natl Acad Sci USA. 1999 May 11;96(10):5844-9.41. Cho S, Jang S, Chae S, Chung KM, Moon YH, An G, et al. Analysis of the C-terminal region of Arabidopsis thaliana APETALA1 as a transcription activation domain. Plant Mol Biol. 1999 Jun;40(3):419-29.42. Ernst HA, Olsen AN, Larsen S, Lo Leggio L. Structure of the conserved domain of ANAC, a member of the NAC family of transcription factors. EMBO Rep. 2004 Mar;5(3):297-303.43. Brent R, Ptashne M. A eukaryotic transcriptional activator bearing the DNA specificity of a prokaryotic repressor. Cell. 1985 Dec;43(3 Pt 2):729-36.44. Tan J, Jin M, Wang J, Wu F, Sheng P, Cheng Z, et al. OsCOLlO, a CONSTANS-Like Gene, Functions as a Flowering Time Repressor Downstream of Ghd7 in Rice. Plant Cell Physiol. 2016 Apr;57(4):798-812.45. Steinbach Y. The Arabidopsis thalianaCONSTANS-LIKE 4 (COL4) - A Modulator of Flowering Time. Front Plant Sci. 2019 May 28; 10:651.46. Nemoto Y, Nonoue Y, Yano M, Izawa T. Hdl,a CONSTANS ortholog in rice, functions as an Ehdl repressor through interaction with monocot-specific CCT-domain protein Ghd7. Plant J. 2016 May;86(3):221-33.47. Tiwari SB, Shen Y, Chang H-C, Hou Y, Harris A, Ma SF, et al. The flowering time regulator CONSTANS is recruited to the FLOWERING LOCUS T promoter via a unique cis-element. New Phytol. 2010 Jul;187(l):57-66.48. Robson F, Costa MM, Hepworth SR, Vizir I, Pineiro M, Reeves PH, et al. Functional importance of conserved domains in the flowering-time gene CONSTANS demonstrated by analysis of mutant alleles and transgenic plants. Plant J. 2001 Dec;28(6):619-31.49. Staller MV, Ramirez E, Kotha SR, Holehouse AS, Pappu RV, Cohen BA. Directed mutational scanning reveals a balance between acidic and hydrophobic residues in strong human activation domains. Cell Syst. 2022 Apr 20;13(4):334-345.e5.50. Sigler PB. Transcriptional activation. Acid blobs and negative noodles. Nature. 1988 May 19;333(6170):210-2.Attorney Docket: 2025-122-02 Lawrence Berkeley National Laboratory51. Weigel D, Glazebrook J. Arabidopsis: A Laboratory Manual. 1st ed. Cold Spring Harbor, N. Y: Cold Spring Harbor Laboratory Press; 2002.52. Unable to find information for 105485.53. Emenecker RJ, Griffith D, Holehouse AS. Metapredict: a fast, accurate, and easy-to-use predictor of consensus disorder and structure. Biophys J. 2021 Oct 19;120(20):4312-9.
[0079] It is to be understood that, while the invention has been described in conjunction with the preferred specific embodiments thereof, the foregoing description is intended to illustrate and not limit the scope of the invention. Other aspects, advantages, and modifications within the scope of the invention will be apparent to those skilled in the art to which the invention pertains.
[0080] All patents, patent applications, and publications mentioned herein are hereby incorporated by reference in their entireties.
[0081] The invention having been described, the following examples are offered to illustrate the subject invention by way of illustration, not by way of limitation.Example 1High throughput characterization of transcriptional activation domains in plant cells
[0082] Transcriptional regulatory domains control a myriad processes in plant growth, development, and responses to the environment. However, the lack of high-throughput assays to study protein-coding elements in plant cells has limited the study of plant transcriptional regulators. We developed ENTRAP-seq (Enrichment of Nuclear Trans-elements Reporter Assay in Plants), a method that delivers protein-coding libraries to drive a nuclear magnetic sorting reporter, enabling sequencing-based, multiplexed measurement of the transactivation activity of thousands of protein variants expressed in plant cells. We combined ENTRAP-seq with machine learning to scan the plant virus ORFeome for protein domains capable of regulating transcription, discovering hundreds of potential regulatory domains in structural proteins and enzymes not previously known to be involved in gene regulation. We benchmarked ENTRAP-seq with a comparable approach in yeast and discovered importantAttorney Docket: 2025-122-02 Lawrence Berkeley National Laboratorydiscrepancies between these two systems. Finally, we used machine-based design to guide semi-rational engineering of an Arabidopsis activator transcription factor to fine tune its activity. ENTRAP-seq opens the door for functional genomic approaches to characterize natural and synthetic diversity in plants.
[0083] Here we introduce ENTRAP-seq (Enrichment of Nuclear Trans elements Reporter Assay in Plants), an new MPRA approach based on magnetic sorting of isolated nuclei and the first MPRA capable of measuring trans-acting elements in plant cells. We deployed this method in leaves of N. benthamiana expressing gene libraries delivered by Agrobacterium, allowing us to simultaneously measure the transactivation capacity of at least 2000 protein variants in planta. We combined this technology with a custom machine learning pipeline to predict and experimentally validate ADs across the ORFeome of all sequenced plant viruses found in NCBI. We identified hundreds of viral ADs which are conserved and tend to occur in structural proteins and enzymes not known to be involved in host gene regulation such as capsid proteins and RNA polymerases. We show that these viral ADs hold potential as plantspecific parts for plant synthetic biology. This assay also allowed us to systematically compare AD activity between yeast and N. benthamiana to better delineate the differences in transcriptional regulatory mechanisms between two highly divergent eukaryotes. Finally, we used machine-based design to guide semi-rational mutagenesis of the Arabidopsis activator CONSTANS, identifying sequence features critical for its function and enabling the generation of a new allelic series that includes repressors. ENTRAP-seq should be easily adaptable to other model organisms as it does not require specialized equipment such as cell sorters and involves a one-step sequencing library preparation.RESULTSOptimizing a magnetic nucleus sorting tag as a quantitative reporter.
[0084] To measure the activity of multiple trans elements in parallel, we sought to develop an MPRA based on separating nuclei according to the level of expression of a reporter transgene (Fig. 1, panel A). By placing this reporter under the control of a library of previously characterized trans regulators (ref), we aimed to sort nuclei into two fractions: a pulldown fraction enriched with trans elements that activate the reporter, and a flow-through fraction enriched with repressors and / or inactive elements. Next-generation sequencing can then be used to quantify the relative enrichment of each trans element in each fraction, whichAttorney Docket: 2025-122-02 Lawrence Berkeley National Laboratoryshould be proportional to their activity (z.e., activators or repressors) and strength (Fig. 1, panel A). As the expression platform we used agrobacterium-mediated transient expression in N. benthamiana, also known as agroinfiltration (Fig. 1, panel A). Crucially, it was previously shown that transgene expression in this system follows Poisson-like statistics (23). This makes it possible to minimize the number of cells expressing more than one trans element from the library by infiltrating Agrobacterium cultures at a very low density. Single transgene expression minimizes unwanted interactions that may occur when different trans elements are expressed in the same cell.
[0085] To link reporter expression to nucleus sorting, we used a chimeric tag composed of a fusion of a biotin acceptor peptide to an outer nuclear envelope targeting domain (hereafter ONEtag) which can be biotinylated by a coexpressed BirA transgene using endogenous biotin. Nuclei extracts incubated with streptavidin magnetic beads can then be sorted using magnets into two fractions, flow-through and pulldown (Fig. 1, panel A). Similar approaches have been used to purify nuclei from specific cell types in transgenic plants (24) but there are no reports of magnetic sorting of agroinfiltrated N. benthamiana tissues. More importantly, it is not clear that magnetic nucleus sorting has the sensitivity to distinguish quantitative differences in ONEtag expression levels among cells. To optimize magnetic nucleus sorting as a quantitative readout of transcriptional activity in agroinfiltrated N. benthamiana, we pursued two design goals. First, the transiently expressed ONEtag should localize to the nuclear envelope, as determined by the subcellular localization of a GFP fusion. Second, as for any sensitive quantitative reporter, the level of accumulation of the ONEtag must correlate with the transcriptional activity of the promoter driving its expression.
[0086] As the first candidate ONEtag, we tested a sequence previously used to isolate nuclei from specific tissues in Arabidopsis, the Arabidopsis RanGAP WPP domain (24). We also transiently expressed a Histone 2B-mScarlet nuclear marker (hereafter H2B-RFP) to confirm the subcellular localization of this tag. When this ONEtag was transiently expressed in N. benthamiana, it did not encircle the H2B-RFP signal as expected for nuclear envelope proteins (Fig. 1, panel B). We replaced Arabidopsis RanGAP WPP by its closest A. benthamiana homolog, but this protein also had the wrong localization pattern (Fig. 1, panel C). The C-terminus of WPP proteins has also been used as an outer nuclear envelope targeting domain in plants (25). We therefore tested the C-terminal half of the closest N benthamiana homolog of Arabidopsis WIP1 but this ONEtag did not display nuclearAttorney Docket: 2025-122-02 Lawrence Berkeley National Laboratoryenvelope localization. We next tested 7 protein domains that localize to the outer nuclear envelope in their native context, including the C-terminus of two tomato WIP proteins (26). Some of these candidates showed the right localization pattern when expressed transiently in N. benthamiana (Fig. 7, panel A). Among these, we chose the C-terminal half of tomato WIP1 and 2 (S1WIP1 / 2-C) for further characterization (Fig. 1, panel B).
[0087] We next focused on the second design criterion, that is, ensuring that the degree of ONEtag protein accumulation correlates with the transcriptional activity of the promoter driving its expression. To measure promoter activity independent of ONEtag protein abundance, we used an RFP-T2A-ONEtag fusion (Fig. 1, panel C). RFP fluorescence intensity was used as a proxy for promoter activity while GFP fluorescence intensity provided a metric for ONEtag accumulation. To drive the RFP-T2A-ONEtag reporter, we placed this transgene under the control of a minimal 35S promoter with upstream Gal4 DNA binding sites (UAS-min35S-RFP-T2A-ONEtag). To activate expression of this reporter we coexpressed it in N. benthamiana with the Gal4 DNA binding domain alone (Gal4DBD) or fused to the strong VP16 activator (Gal4-VP16). As expected, the level of RFP fluorescence was higher in leaves coexpressing the S1WIP1-C ONEtag and Gal4DBD-VP16 compared to Gal4DBD (Fig. 1, panel D). However, GFP fluorescence was comparable between Gal4DBD-VP16 and Gal4DBD, indicating that the increase in transcriptional activity driven by the VP 16 fusion was buffered at the level of S1WIP1-C ONEtag protein accumulation (Fig. 1, panel D). Cell microscopy confirmed that the ONEtag and RFP proteins are efficiently separated after being produced from the same transcripts (Fig. 7, panel B).Removing S1WIP1-C was sufficient for GFP fluorescence to increase in response to VP 16, similar to RFP (Fig. 7, panel C). We therefore replaced S1WIP1-C with S1WIP2-C. For this ONEtag, GFP and RFP accumulated in response to VP 16 in a linear fashion, showing that the accumulation of this tag closely correlates with the activity of the promoter driving it (Fig. 1, panel E). Removing RFP-T2A from the constructs made accumulation of S1WIP1-C ONEtag slightly responsive to Gal4-VP16 but to a far lesser degree than S1WIP2-C (Fig. 7, panel D) To further confirm that the UAS-min35S-RFP-T2A-ONEtag construct containing S1WIP2-C acts as a quantitative reporter of transcriptional activity, we coexpressed it with 8 previously generated Gal4 fusions spanning a wide dynamic range in activity (27) and found RFP and GFP fluorescence to correlate well across combinations (R2= 0.91, Fig. 1, panels F and G). Hence, accumulation of the S1WIP2-C ONEtag is highly sensitive and quantitatively reflects the transcriptional activity of the promoter driving its expression.Attorney Docket: 2025-122-02 Lawrence Berkeley National Laboratory
[0088] We previously determined that a low Agrobacterium OD of ~ 0.0025 is optimal for expressing libraries of trans elements in N. benthamiana as it maximizes the number of transformed cells while minimizing the fraction of these cells expressing more than one transgene. At this OD, »10% of leaf cells are transformed and =90% of these cells express a single T-DNA (Alamos et al. 2025). To determine the efficiency and yield of nuclei purified under these conditions, we infiltrated the S1WIP2-C UAS-min35S-RFP-T2A-ONEtag reporter at an OD of 0.0025. We coinfiltrated constitutively expressed Gal4DBD-VP16 and BirA both at a high OD of 0.1 which ensures that all cells express these two transgenes. To purify and sort nuclei we developed a protocol based on pipelines optimized for other plant species (Materials and Methods) (25,28). Using this protocol we were able to pull down about 1 million nuclei from about 20 fully infiltrated leaves. Virtually all the nuclei in the pulldown expressed RFP, reflecting an extremely small fraction of false positives in the purification (Fig. 8, panels A and B). The estimated number of transformed cells in the sample (» 30 million, see calculation in Fig. 8, panel C) outnumbers that of the purified nuclei by about an order of magnitude, suggesting that many nuclei that do express the ONE-tag are not pulled down due to insufficient expression levels (Fig. 8, panel C).Small-scale library validation of ENTRAP-seq
[0089] We next sought to validate our approach against an established measurement method (29). To this end we generated a small library composed of 26 synthetic TFs consisting of 53 previously characterized amino acid (aa) fragments or ‘tiles’ fused to Gal4DBD (16). Based on previous measurements, we chose fragments expected to span a large dynamic range in activity, from repressor to strong activators (16). We placed these Gal4DBD fusion tiles under the control of the constitutive pMas promoter and cloned them in an Agrobacterium expression plasmid containing both the S1WIP2-C RFP-T2A-ONEtag construct under the control of UAS-min35S and a constitutive BirA transgene (Fig. 2, panel A). All three cassettes were placed in the same T-DNA to ensure that biotinylated ONEtag expression occurs exclusively in cells expressing a synthetic TF. To determine the activity of each tile, we infiltrated each construct individually at an OD of 0.2 and measured the tissue RFP fluorescence normalized to the no-tile Gal4DBD control (Fig. 2, panel B). The very low basal activity of the min35S promoter prevents detecting repression using fluorescence reporter assays. Hence, in the case of repressor tiles we coinfiltrated the tiles with a construct containing a synthetic promoter with embedded Gal4 binding sites, which has a weak basalAttorney Docket: 2025-122-02 Lawrence Berkeley National Laboratoryexpression level.
[0090] Next, we combined these 26 Agrobacterium cultures carrying each of our control tiles in equal OD ratios and infiltrated the mix at a final OD of 0.0025. Nuclei purified from these leaves were subjected to magnetic sorting to obtain two fractions, pulldown and flow-through. Total DNA was extracted from each sample and amplicon sequencing of the T-DNA tile region was used to determine the abundance of each tile in each fraction. We found the level of enrichment to correlate very well with reporter fluorescence (Spearman’s p = 0.91) indicating that ENTRAP-seq has a high degree of predictive accuracy in terms of TF quantitative strength (Fig. 2, panel C). Overall, these results validate ENTRAP-seq as a way to measure trans element activity in plant cells.Accuracy and reproducibility in large libraries of viral protein tiles
[0091] We next sought to leverage the ENTRAP-seq technology to discover entirely new transcriptional regulators. Plant pathogen attack is usually linked to widespread transcriptomic changes in the host through the action of pathogen-encoded transcriptional regulators (30). There are well-known examples of such regulators delivered by bacteria into plant cells but how plant viruses manipulate host transcription is much less understood (31). Transcriptional reprogramming may also play a role in altering the behavior of animal vectors on which most plant viruses rely for transmission (32,33). Plant viruses have very small genomes (typically in the order of 10-15 Kbp) and code for just a few proteins (normally about 4), none of which resemble known eukaryotic transcription factors (34). A better molecular understanding of the viral transcriptional arsenal could help devise new crop protection strategies. To explore the mechanisms of transcriptional regulation by these pathogens, we performed a biased, diversity-maximized search for activators across all plant virus genomes in the NCBI database (Fig. 3, panel A). We tiled the protein coding regions of all annotated plant viruses using 53 aa windows and 10 bp overlaps. Next, to estimate the likelihood of each tile as a putative AD, we used PADDLE, a deep convolutional neural network that predicts an evolutionary conserved class of eukaryotic ADs known as acidic ADs (11). Although PADDLE was trained on yeast data using yeast-derived protein sequences, we previously demonstrated that it can identify some ADs from plants (16).Consequently, only tiles with the highest activator probability values were selected (Fig. 3, panel A). Finally, to avoid redundant tiles coming from closely-related viruses, we maximized sequence diversity by clustering and selected sequences that maximize theAttorney Docket: 2025-122-02 Lawrence Berkeley National LaboratoryHamming distance between binary protein encodings (Fig. 3, panel A).
[0092] Although our nuclei enrichment method performed well on the control set of 26 tiles (Fig. 2, panel C), the scalability of ENTRAP-seq to larger libraries was not immediately clear. To address this question, we created 4 nested libraries of 250, 500, IK, and 2K viral tiles (Fig. 3, panel A). All except for the 2K library also contained the 26 tile control set for which we had previously obtained single infiltration fluorescence data (Fig. 2, panel C). For the 2K library, a new set of 26 viral tiles was measured individually in a fluorescence plate reader. These internal controls allowed us to validate the assay by comparing the activity of these tiles in terms of reporter fluorescence and tile enrichment. Across all libraries, we found that the activity of a given control tile as measured individually in a fluorescence plate reader correlates very well with its enrichment following magnetic pulldown (Spearman’s p « 0.9) (Fig. 3, panels B-E). This was true for two biological replicates of each library (Fig. 3, panels B-E). These validation experiments allowed us to obtain a calibration value to classify tiles into activators and not activators based on their sequencing enrichment. To this end, we fitted the validation data to a sigmoidal curve and calculated the enrichment value corresponding to the midpoint of this sigmoid plus its estimation error (Fig. 3, panels B-E). This yielded an enrichment value that was subsequently used as a cutoff to classify viral tiles as activators (Fig. 3, panels B-E).
[0093] When the enrichment of all tiles was considered, we found that biological replicates correlate well (Pearson’s r ~ 0.6) and this correlation increased substantially by applying even modest library coverage cutoffs (Fig. 3, panel F). We found no correlation between tile coverage in the library and their enrichment ratio (Fig. 9). Because of the nested nature of the libraries, it was also possible to compare tile enrichment across libraries. This exercise revealed a high degree of reproducibility even across libraries (Pearson r = 0.59-0.8) (Fig. 3, panel G). Thus, our assay is accurate and reproducible in libraries of up to 2K tiles.Identification of activation domains in plant viral proteins
[0094] Our pipeline to discover viral activation domains combining machine learning with high throughput measurements yielded hundreds of protein stretches resembling acidic ADs capable of activating the reporter, confirming that PADDLE has good predictive capacity in plants (Fig. 4, panel A). These tiles are found all throughout the phylogenetic tree of plant viruses (Fig. 4, panel A). Two large families of plant DNA viruses (Geminiviridae andAttorney Docket: 2025-122-02 Lawrence Berkeley National LaboratoryCaulimoviridae) as well as multiple +ssRNA families (in particular Potyviridae and Betaflexiviridae) were particularly rich in acidic ADs (Fig. 4, panel A). This is consistent with a recent survey of ADs in human viruses that found that the strongest ADs are from ssDNA viruses (19). We did not find any predicted acidic ADs in only 4 relatively rare families: Amalgaviridae, Aspiviridae, Mitoviridae, and Nanoviridae. In general, our search algorithm based on PADDLE performed well in terms of predicting ADs; -50% of the tested tiles qualify as activators based on our calibration thresholds, although there was substantial variation in predictive accuracy across taxa (Fig. 4, panels A and B).
[0095] To better understand the nature of these potential regulators, we performed GO term enrichment analysis. We found activator tiles to be present in all protein classes, although we note that due to the biased nature of our search not all classes are represented equally in our libraries (Fig. 4, panel C). Four kinds of viral proteins showed a notable enrichment of activator tiles: geminiviral AL2-like proteins, RNA-dependent RNA Polymerases (RdRp), helicases, and helical capsid proteins (Fig. 4, panel C). The AL2 protein, also known as TrAP (transcriptional activator protein), is involved in transactivating viral promoters in Geminiviridae and has been shown to regulate genomic promoters by physically interacting with host TFs (35,36). AL2 lacks a DNA-binding domain but contains an C terminal acidic region that can transactivate a synthetic reporter when fused to Gal4DBD (37). Thus, the recovery of strong ADs in AL2-like proteins using ENTRAP-seq validates our framework for identifying viral-encoded transcriptional regulators. Our high-resolution tiling of these proteins allowed us to precisely map the boundaries of their putative ADs. Consistent with the C terminus of AL2 being important for transactivation, we found that ADs are consistently located in three nearby positions within a highly disordered region in the C-terminus of diverse AL2 proteins (Fig. 4, panel C). The positions of RdRp activator tiles are also relatively conserved but unlike AL2 these putative ADs are clustered in multiple distinct regions throughout the protein, most of which are predicted to fold into stable structures (Fig.4, panel D). Similar to RdRp, activator tiles in helical capsid proteins are clearly clustered in a few conserved hot spots throughout the protein, only some of which are predicted to be disordered (Fig. 4, panel E). These data suggest that a dedicated regulatory protein like AL2 might activate transcription in a similar manner as canonical eukaryotic TFs while multifunctional viral proteins may repurpose stably folded catalytic or structural domains to accomplish this task.Attorney Docket: 2025-122-02 Lawrence Berkeley National Laboratory
[0096] From an applied perspective, the discovery of these viral regulators prompted us to consider their potential as novel plant synthetic biology tools. Notably, many of the most widely used genetic parts in plant and mammalian genetic engineering - such as the VP 16 AD, the 35S promoter, and the SV40 NLS - originate from plant and animal viruses.Sourcing tools from plant viruses rather than animal viruses may enhance the biosafety profile of modified cultivars and facilitate regulatory approval. To find potent and compact activators that could serve as alternatives to existing field standards, we individually cloned 20 tiles that were among the most enriched in at least one library. We then tested them individually using the same Gal4-UAS fluorescence reporter assay described above, side by side with two potent and popular activation domains used in the field, VP 16 and VPR (38). All 20 tiles strongly activated the reporter (Fig. 10) and 4 performed as well or better than VP16 and VPR (Fig. 4, panel G). To determine if these activation domains perform well in different contexts, we fused them to dCas9 and tested their activity upon recruitment to a synthetic promoter driving GFP as a reporter (Fig. 4, panel H) (39). dCas9-VPR outperformed all other fusions and one tile was stronger than VP 16 when fused to dCas9 (Fig. 4, panel H). Since VPR is considerably larger than our viral tiles (553 vs 53 aa), this compact viral AD may be advantageous for vectors with a limited size capacity. In addition to minimizing construct size, our viral tiles offer a diverse set of genetic parts to reduce unintended consequences in synthetic programs, including cross-interactions with modules sharing identical parts and gene silencing arising from context-dependent effects.Conservation of AD function between two distant eukaryotes.
[0097] Recently, massively parallel reporter assays in S. cerevisiae (yeast) have identified plant protein sequences encoding ADs (12,16). Deriving insight about plant ADs from these experiments in a distantly-related host depends on the degree to which transactivation mechanisms are conserved between these two systems. It is well documented that there is substantial conservation of transcriptional activation mechanisms between yeast and plants. Decades of insights about plant TFs derived from yeast-based assays and our own results showing that a model trained in yeast predicts plant viral ADs much better than random support this idea. Yet, it is not known the degree to which each model organism has its own taxa-specific regulatory pathways. To date, the low throughput of reporter assays in plants has prevented comprehensive evaluation to systematically answer this question. To systematically study whether there are yeast or N. benthamiana-specific ADs, we tookAttorney Docket: 2025-122-02 Lawrence Berkeley National Laboratoryadvantage of an existing dataset where thousands of protein tiles from Arabidopsis TFs were tested in yeast (12). We leveraged ENTRAP-seq to test a subset of these tiles in N. benthamiana and compare their activity across model systems. We randomly selected 250 tiles while keeping the same distribution of yeast transcriptional strengths (referred to as PADI scores) from the original library. We then cloned this library in the same vector used for our viral libraries and performed a nucleus enrichment experiment. Comparing the rank ordering of activity between these two systems revealed very limited correlation (Spearman’s p = 0.18, p = 0.0075)(Fig. 5, panel A). Indeed, numerous strong yeast activators were highly depleted from the ENTRAP-seq pulldown and multiple highly enriched tiles in N. benthamiana were not found to be activators in yeast (Fig. 5, panel A).
[0098] Because yeast-based MPRAs are heavily biased towards identifying acidic ADs, we hypothesized that tiles that were not found to be activators in yeast might belong to other kinds of ADs. Among the tiles that had a ENTRAP-seq enrichment > 1.2 we found two Q-rich sequences that were not classified as activators in yeast. Q-rich stretches are well known to be involved in transactivation in plants. The first of these polyQ ADs is located in the middle region (MR) of ARF19 (Fig. 5, panel B). The MR is important for transactivation in activator ARFs (40) but the yeast assay mapped the ADs of ARF19 and other activator ARFs to regions flanking the MR (12). The second polyQ stretch belongs in the C terminus of the AGAMOUS-LIKE gene ALG65, a region that is thought to contain the activation domain in this family of TFs (Fig. 5, panel C) (41).
[0099] An alternative hypothesis for why ADs can be active in plants but not in yeast is that these tiles are not ‘bona fide’ ADs, namely, intrinsically disordered regions that contact the core transcriptional machinery. Instead, these tiles may code for folded protein domains that bind plant-specific TFs that in turn contain true ADs of a conserved canonical kind which themselves do activate transcription in yeast. To explore this possibility, we calculated the predicted disorder of tiles in the library and compared this prediction with their ENTRAP-seq enrichment. We found these two metrics to be completely uncorrelated (Spearman’s p = 0.13, p = 0.054) and tiles that are active in plants (enrichment >1.2) are equally likely to be structured as to be disordered (Fig. 5, panel D). Thus, tiles with a plant-specific bias do not necessarily form folded domains. However, among highly structured tiles we found cases that do fit our initial hypothesis. For example, a tile in the NAC001 TF containing part of a structured domain involved in homo- and hetero-dimerization within NAC family TFs wasAttorney Docket: 2025-122-02 Lawrence Berkeley National Laboratoryfound to be highly active in plants but not in yeast (Fig. 5, panel E) (42). The NAC TF family is plant-specific and contains acidic ADs in their C terminal half that are potent activators in yeast (Fig. 5, panel E). Thus, in N. benthamiana, this NAC001 tile might simply recruit endogenous NAC activators which, in turn, contain ADs that are active in both N. benthamiana and yeast. In yeast however, this NAC001 tile may be incapable of activating the reporter because this organism lacks interacting NAC partners. Hence, in at least some cases the fact that some tiles that are active in plants fail to activate transcription in yeast can reasonably be considered a feature and not a bug: it selects for ‘bona fide’ ADs rather than domains that bind plant TFs.
[0100] We confirmed that the polyQ ADs of ARF19 and AGL65 as well as the NAC001 AD activated the reporter in our fluorescence plate reader assay (Fig. 5, panel F). On the other hand, 4 / 5 randomly selected ADs that were highly active in yeast but depleted in ENTRAP-seq did not activate the fluorescence reporter, in fact, most acted as repressors (Fig.5, panel G). Taken together, these results are consistent with there being plant-specific as well as yeast-specific AD tiles but it remains unclear if this reflects a true divergence between these two taxa at the level of mechanisms to activate transcription. To better understand the degree of conservation of ADs between these two model eukaryotes, it will be necessary to leverage ENTRAP-seq to more systematically measure all tiles across all Arabidopsis TFs in an unbiased and systematic manner. Finally, these findings, although limited in scope, show that it is wise to exercise some caution when interpreting tile MPRA data of plant proteins tested in yeast because both false positives and false negatives can be encountered when going from one system to the other.Rationally tuning the activity of a plant TF
[0101] One of the implicit assumptions AD recruitment assays is that TFs are largely modular (43). If this is the case, it may be possible to study and engineer plant TFs in a high throughput manner by isolating, mutating and screening their ADs for altered functionality. To test this idea, we sought to generate coding variants of the Arabidopsis activator TF CONSTANS (CO) with altered strength (z.e., degrees of activation) and regulatory role (activation or repression of target genes). Natural variation in CO and its homologs is associated with flowering time, a key agronomic trait. Although Arabidopsis CO appears to act exclusively as an activator, related CO-like genes in this and other species can act as repressors, suggesting that it is feasible to switch the CO regulatory role via coding mutationsAttorney Docket: 2025-122-02 Lawrence Berkeley National Laboratory(44-46). In agreement with the role of CO in its native context and previous reports, transient expression in N. benthamiana of a fusion between CO and a blue fluorescent protein (BFP-CO) strongly activates expression of the FT promoter (1.9 kb upstream of the ATG, hereafter proFT) as measured by a GFP reporter assay (Fig. 6, panel A) (47).
[0102] CO contains a poorly conserved, highly disordered large middle region that was shown to be sufficient for transactivation in a Gal4 recruitment assay (Fig. 6, panel B) (47). Although multiple CO alleles have been identified in random mutagenesis screens, all lie outside this middle region and are loss-of-function (Fig. 6, panel B) (48). To better define the position of the CO AD within this middle region, we leveraged PADDLE and TAD A, two models that predict acidic ADs based on yeast data (10,12). Both models have a high degree of agreement and point to a region around aa position 175 as the putative CO AD (Fig.6, panel B). We therefore selected a 69 aa window in this region as the putative AD (Fig. 6, panel B). To explore the sequence space of the CO AD, we generated a library of 350 tiles carrying 1-4 aa substitutions and including the wild-type AD as a control. The substitutions were designed rationally to either increase or decrease AD strength based on sequence features important for acidic AD function, namely 1) depletion of positive residues (R and K), 2) enrichment of negative residues (D and E), 3) enrichment of hydrophobic residues (particularly aromatics and leucine), 4) depletion of continuous stretches of hydrophobic residues, and 5) lack of stable secondary structure (6,10,49,50). Following the same rationale, we also mutated every residue to K, P, W, and D. As internal controls we included 5 wt tiles. Finally, we introduced 10 random synonymous mutations in each tile in the library to better distinguish between highly similar tiles from sequencing. Following the same strategy used for our previous experiments, we cloned these tiles as Gal4DBD fusions in our magnetic sorting reporter and performed a ENTRAP-seq assay (Fig. 6, panel C).
[0103] The enrichment of the CO AD tiles spanned a range of values comparable to other libraries and the enrichment of WT tiles was highly reproducible (1.12 ± 0.02). Perhaps not surprisingly, most tiles were loss-of-function mutants, z.e., less enriched than WT (Fig. 6, panel D). We found a moderate agreement between tile activity as measured by ENTRAP-seq and the predictions from PADDLE and TADA (Spearman’s p = 0.38 and 0.4, respectively) and the two models largely agreed with one another (Pearson’s r = 0.89) (Fig.11). Thus, predictive models could be used in the future to aid in the design of mutant AD screens. Comparing the activity of each tile to its biochemical properties showed that, asAttorney Docket: 2025-122-02 Lawrence Berkeley National Laboratoryexpected for an acidic AD, negative charge and hydrophobicity have a significant correlation with activity (Spearman’s p = -0.34 and 0.24, respectively, Fig. 12). Throughout the AD, mutation of residues to K tended to decrease the activity and most of the strong loss of function AD alleles are K substitutions (Fig. 6, panels E and F). The majority of the gain-of-function single mutants correspond to W or D substitutions (Fig. 6, panels E and F). Mutating residues to P, which severely disrupts protein secondary structure, rarely had strong effects (Fig. 6, panels E and F). These results are all consistent with the CO AD behaving like a classic intrinsically disordered acidic AD and highlight the power of combining predictive models with semi-rational mutagenesis guided by known AD compositional biases.
[0104] To test the effect of these mutations in the context of the full-length CO protein, we chose 10 putative loss-of-function and gain-of-function alleles among the tiles at either end of the enrichment value distribution. We then introduced each of these 20 aa substitutions into the full-length BFP-CO expression construct and tested their effect one by one using the proFT fluorescence reporter assay we previously established (Fig. 6, panel G). As controls we also cloned three previously isolated semidominant loss-of-function alleles corresponding to point mutations outside the AD obtained through EMS mutagenesis. Out of 10 predicted loss-of-function CO mutants, 7 were significantly weaker activators than WT and 2 of those were as weak as classic alleles. The M186P mutant behaved as a gain of function allele, in contrast to its activity as a Gal4 DBD fusion tile (Fig. 6, panel H). The EMS mutant controls as well as some of our isolated alleles switched CO activity from an activator into a repressor, consistent with the EMS mutants being semidominant in Arabidopsis (48). Out of the 10 predicted gain-of-function mutant alleles, 5 were stronger activators than WT (Fig. 6, panel H). Among the rest, 4 behaved as activators but were not statistically stronger than WT and one putative gain of function allele (Y194W) was a slightly weaker activator than WT. We conducted an independent replicate of this whole experiment and obtained similar results (r = 0.92, Fig. 13). Collectively, these data demonstrate that tile activity in the context of an ENTRAP-seq assay can be predictive of tile function within the original TF protein environment. This allowed us to rapidly engineer an entirely new allelic series of a plant transcription factor, including switching its function from activator to repressor.DISCUSSION
[0105] Large scale functional genomics assays are necessary to provide meaning toAttorney Docket: 2025-122-02 Lawrence Berkeley National Laboratoryplant genetic variation, both to make sense of natural diversity and to guide engineering efforts. Methods such as DAP-seq and STARR-seq have begun to fill important gaps in our understanding of plant gene regulation by characterizing TF DNA binding preferences and cis regulatory regions, respectively. ENTRAP-seq complements these approaches by allowing the high-throughput mapping and characterization of TF regulatory domains in plant cells.
[0106] Natural and engineered non coding variation has been leveraged to fine tune crop quantitative traits. We envision that by characterizing mutant libraries of plant TFs this approach can now be also applied to coding variants. Further, by combining ENTRAP-seq with plant-specific models of AD activity it may be possible to rationally engineer agronomically-relevant TFs with altered functionality in a predictive fashion.
[0107] Recent studies of plant cis-regulatory grammar have discovered fundamental mechanistic differences with other eukaryotes. It should come as no surprise if this also applies to the mode of action of TFs encoded in the genomes of plants and their microbial parasites.MATERIALS AND METHODSData, code, and sequencing availability:
[0108] All code and models related to this study are publicly available on GitHub (github.com / shih-lab / magnets). Raw sequencing reads are publicly available through the NCBI SRA Database under BioProject accession PRJNA1254296.
[0109] Nucleus Purification Buffer (NPB): NPB was prepared following the recipe from Wang & Deal 2015: 20 mM MOPS pH 7, 40 mM NaCl, 90 mM KC1, 2 mM EDTA pH 8, 0.5 mM EGTA pH 8, 0.5 mM spermidine, 0.2 mM spermine, 1 complete protease inhibitor tablet per 100 ml. A 5x stock solution was prepared adding everything except for fresh ingredients: spermidine, spermine and protease inhibitors. The fresh ingredients were added to the lx solution up to one day prior to nucleus pulldown. NPBt was prepared following the same recipe and protocol except that 0.1 % (v / v) Triton X-100 was added up to one day before nucleus pulldown.
[0110] Preparing tissue for nucleus sorting: Agrobacterium cultures containingAttorney Docket: 2025-122-02 Lawrence Berkeley National Laboratorygene libraries were diluted to a final OD of 0.0025 in IB and infiltrated into 104-week old N. benthamiana plants (see Materials and Methods: Agroinfiltration). The full area of true leaves 6-8 of each plant was infiltrated. 3 days post infiltration, leaves were harvested and the mid vein was removed. A ~5mm perimeter around the edge of the leaves was discarded as well.10 g of leaf material was then chopped into ~lcm2pieces using a razor blade. The chopped leaves were submerged in 50 ml of nucleus purification buffer (NPB) in a beaker and placed in a vacuum chamber for 10 min to infiltrate NPB into the tissue (see Materials and Methods: Nucleus Purification Buffer (NPB)). Further rounds of vacuum filtration were applied until the tissue was completely soaked in NPB. Next, the tissue was washed 3 times with tap water and tapped dry with paper towels. Finally, the leaf material was flash frozen in liquid nitrogen, ground into a very fine powder using mortar and pestle and stored at -80 C.
[0111] Nucleus sorting: Frozen ground tissue (see Materials and Methods: Preparing tissue for nucleus sorting) was resuspended in 100 ml of ice-cold NPB and passed through a 70 um strainer into 250 ml tubes to separate nuclei from cells and other larger leaf fragments, keeping the material on ice at all times. This filtrate was centrifuged at 500 G for 10 minutes at 4 C. The pellets from both tubes were combined by resuspending them in 20 ml of NPB. The resuspension was passed through a 100 um strainer to remove remaining pieces of tissue. In parallel, 100 ul of MyOne streptavidin dynabeads were washed by resuspending them in 1.5 ml of NPB, separating them in a magnetic rack and resuspending in 100 ul of NPB. The washed dynabeads were then added to the resuspended nuclei and the mix was incubated for 30 minutes shaking gently in a cold room. All following steps were carried out in a cold room. The nuclei were diluted in NPBt to 100 ml final split into 2 50 ml tubes. The samples were then placed in a magnetic rack for 30 minutes to pull down nuclei. The supernatant was removed and centrifuged for 10 min at 500 G, resuspended in 25 ml of NPB per tube and centrifuged again at 500 G for 10 min to obtain a pellet corresponding to the flowthrough sample. The pulldown from the first magnetic separation was washed twice by resuspending it in 50 ml of NPBt and placing it in the magnetic rack for 20 min. The washed nuclei were next resuspended in 15 ml of NPBt in a 15 ml tube and placed in the magnetic rack again for 20 min. The pellet from this separation was resuspended in 3 ml of NPB and 10 ul of this sample were taken for imaging. The rest of the sample was centrifuged at 1000 G for 10 min to obtain a pellet corresponding to the pulldown sample. The pellets corresponding to the flowthrough and pulldown samples were resuspended in 1 mL and 200 ul of CTAB, respectively (100 mM Tris-Cl pH 8, 20 mM EDTA pH 8, 1.4 M NaCl, 2% (w / v)Attorney Docket: 2025-122-02 Lawrence Berkeley National Laboratorycetyltrimethyl ammonium bromide, 1% PVP 40,000). These samples were stored at -20 C until DNA extraction.
[0112] Nucleus DNA extraction: Purification of DNA from the flowthrough and pulldown samples was carried out based on a previously published protocol (51). CTAB-resuspended pellets were incubated at 65 C for 30 minutes vortexing every 10 minutes. A volume approximately equal to the pellet volume of phenol:chloroform:isoamyl alcohol 25:24:1 v / v was added per tube and tubes were vortexed thoroughly. Samples were centrifuged at 20K G for 2 min at room temperature. The top aqueous layer was removed and mixed with an equal volume of CT AB in a new tube. Samples were vortexed and incubated at 65 C for 20 minutes. A volume of chloroform:isoamyl alcohol 96:4 v / v equal to the volume of CTAB added in the last step was added to each tube. Samples were vigorously vortexed and centrifuged at 20K G at room temperature for 2 minutes. The top aqueous layer was transferred to a new tube and 70% of this volume of isopropanol was gently added to the wall of each tube. Samples were mixed gently by inverting 5-10 times and placed and -20 C for 20 min. The DNA was pelleted by centrifugation at 20K G for 15 min. The supernatant was removed and the pellets were washed with ice-cold 70% ethanol. Ethanol was removed and the pellets were air dried on a bench top prior to resuspending them in either 54 ul (pulldown) or 108 ul (flow-through) of water.
[0113] Sequencing library preparation: For each sample, a 480 ul PCR reaction was prepared containing: 240 ul of Q52x master mix, 168 ul of water, 24 ul of nucleus DNA extraction, and 24 ul of a lOuM stock of each primer. Primers were designed to anneal to regions immediately adjacent to the tile sequences and contained Nextera-style sequencing adapters and 8 bp indexes. Throughout this work we used the same number of PCR cycles for all samples, which was determined as follows. We ran qPCR reactions using the pulldown and flow-through DNA samples of 2 replicates of the viral 250 tile library, using the same set of primers used for preparing sequencing libraries. The qPCR Ct value of these reactions was 22-23 cycles. We added 2 more cycles to obtain extra DNA for sequencing, resulting in 25 cycles used for library preparation PCR. The library PCR were run on a 2% agarose gel and bands of the expected size were excised and purified using a Zymo gel purification column following manufacturer instructions. Libraries were eluted in 50 ul of water and stored at -20 C. Samples from the 26 control strains experiments shown in Figure 2 were amplified using the same protocol except that primers did not contain any extensions. The amplicons were then ligatedAttorney Docket: 2025-122-02 Lawrence Berkeley National Laboratory
[0114] DNA Sequencing: The libraries prepared from the control set of 26 mixed strains shown in Figure 2 were sequenced using a Nanopore minlON following the native barcoding kit (SQK-NBD114-24).Designing viral libraries:
[0115] A total of 1,495 plant virus genomes were downloaded from NCBI, yielding 5,607 unique proteins. These proteins were clustered at 90% sequence identity using CD-HIT (52), resulting in 4,537 representative proteins. Each protein was fragmented into 53 AA tiles with a 10 AA stride, generating 190,520 tiles. PADDLE was used to perform inference on each tile. To construct a diverse subset for experimental screening, the top 2,000 tiles with the highest predicted Z-score were binary encoded, and a greedy selection algorithm was applied to maximize the pairwise Hamming distance between selected encodings. This approach prioritized sequences with the most dissimilar binary representations, thereby enhancing diversity in the DNA library.Machine-based predictions of activation domains:
[0116] In addition to PADDLE, TADA was used to predict transactivation strength, and Metapredict (53) was used to identify disorder regions in proteins. Because PADDLE and TADA use different input sizes (53 AA and 40 AA, respectively), CONSTANS and CO variants were tiled with a 1 AA stride, and tile-level predictions were aggregated into residuelevel profiles by averaging the scores of all overlapping tiles at each position. Residues not covered by any tile were assigned a score of zero. PADDLE and TADA predictions were independently min-max normalized to scale scores between 0 and 1 for comparison between models.Calibration of ENTRAP-seq from fluorescence data:
[0117] To model the relationship between ENTRAP-seq and fluorescence measurements, we fit a sigmoid function to the enrichment ratios as a function of logRFP for control tiles. The standard deviation of residuals from the fitted curve was used to estimate confidence bounds. We defined the activation threshold as the upper confidence bound at the sigmoid’s midpoint.flAttorney Docket: 2025-122-02 Lawrence Berkeley National Laboratory
[0118] While the present invention has been described with reference to the specific embodiments thereof, it should be understood by those skilled in the art that various changes may be made and equivalents may be substituted without departing from the true spirit and scope of the invention. In addition, many modifications may be made to adapt a particular situation, material, composition of matter, process, process step or steps, to the objective, spirit and scope of the present invention. All such modifications are intended to be within the scope of the claims appended hereto.
Claims
Attorney Docket: 2025-122-02 Lawrence Berkeley National LaboratoryWhat is claimed is:
1. A method for enriching trans-acting elements comprising: (a) providing a library of trans-acting elements; (b) transforming plant cells with the library, wherein at least some transformed plant cells express an outer nuclear envelope tag comprising a binding-peptide; (c) isolating nuclei from the transformed plant cells; (d) separating nuclei into subpopulations based on the level of expression of the binding-peptide; (e) optionally determining, identifying, or sequencing the trans-acting elements in the isolated nuclei of step (c); (f) optionally determining, identifying, or sequencing the trans-acting elements in each of the separated nuclei subpopulations from claim (d); and, (g) determining or calculating the relative fold difference each kind, type or sequence of the trans-acting elements determined, identified, or sequenced in steps (e) and step (f).
2. The method of claim 1, comprising characterizing the regulatory activity of gene variants from a library within plant cells.
3. The method of claim 1, wherein the binding-peptide and a binding-compound form a specific binding-pair.
4. The method of claim 3, wherein the binding-peptide is an antibody, or an antigen binding fragment thereof, and the binding-compound is an antigen, wherein the antibody, or an antigen binding fragment thereof, specifically binds the antigen.
5. The method of claim 3, wherein the binding-peptide is a first binding-peptide and the binding-compound is a second binding-peptide, wherein the first binding-peptide specifically binds the second binding-peptide.
6. The method of claim 3, wherein the first binding-peptide is an antibody, or an antigen binding fragment thereof, and the second binding-peptide is an antigen, wherein the antibody, or an antigen binding fragment thereof, specifically binds the antigen, or vice versa.
7. The method of claim 3, wherein the binding-peptide is a peptide that specifically binds a metal ion, and the binding-compound is a metal ion.
8. The method of claim 3, wherein the binding-peptide is a polyhistidine tag, such as a polypeptide of six or more histidine residues, and the metal ion is nickel, cobalt, or copper.Attorney Docket: 2025-122-02 Lawrence Berkeley National Laboratory9. The method of claim 3, wherein the binding-peptide is an biotin acceptor peptide, and the method further comprises binding a biotin to the biotin acceptor peptide, wherein the biotin acceptor peptide specifically binds the biotin.
10. The method of claim 3, wherein the binding-compound is bound to a means for separating the nuclei that comprise the binding-peptide from nuclei that do not comprise the binding-peptide.
11. The method of claim 3, wherein the binding-compound is bound to a magnetic support, such as a magnetic bead, or a substrate, such as resin, such as a resin bead or a resin fixed to a fixed support, such as a column.
12. The method of claim 3, wherein the binding-peptide is bound to a biotin, and the binding-compound is a streptavidin which in turn is bound to a magnetic support or substrate.
13. The method of claim 1, wherein the library of trans-acting elements comprises a library of variants of a fusion protein comprising an activator or repressor domain linked to a DNA binding domain.
14. The method of claim 1, wherein the plant cell is a reporter plant cell comprising a two-part reporter gene comprising a surface marker and a fluorescent protein.
15. The method of claim 14, wherein the two-part reporter gene is under the control of a strong promoter and capable of being activated or repressed by the fusion protein or the trans-acting element, such as a transcriptional activator or repressor domain.
16. The method of claim 1, wherein the transforming step comprises one trans-acting element transforming about or at most one plant cell to form a transformed plant cell.
17. The method of claim 1, wherein the plant cells are a whole plant or a part thereof.
18. The method of claim 17, wherein the plant part is a leaf, stem, roots, or seed.
19. The method of claim 1, wherein the plant cells are Nicotiana cells.
20. The method of claim 19, wherein the Nicotiana cells are Nicotiana benthamiana cells.
21. The method of claim 1, wherein the method comprises: (a) providing a library of first constructs, wherein each first construct encodes a trans-acting element operatively linked to a promoter, and the library comprises a plurality of different trans-acting elements; (b) providing a plurality of second constructs, wherein each second construct encoding an outer nuclear envelope tag comprising a biotin acceptor peptide; (c) transforming a plurality of plant cells with the library of constructs and the plurality of second constructs, wherein (1) one first construct transforms about one plant cell to form a transformed plant cell, and (2) the first construct expresses a biotinAttorney Docket: 2025-122-02 Lawrence Berkeley National Laboratoryacceptor peptide which is transported to a nuclear membrane of a nucleus of the transformed plant cell; (d) binding a biotin to each biotin acceptor peptide with a BirA, or an enzymatically active variant thereof comprising an amino acid sequence having at least about 70% amino acid identity with SEQ ID NO: 1, to form a biotin acceptor peptide-biotin complex; (e) isolating a plurality of nuclei from the transformed plurality of plant cells; (f) binding a streptavidin-magnetic bead to the biotin; (g) separating nuclei that comprise a biotin acceptor peptide-biotin complex bound to the streptavidin-magnetic bead from nuclei that do not comprise a biotin acceptor peptide-biotin complex bound to the streptavidin-magnetic bead using a magnetic field; (h) optionally determining, identifying, or sequencing the trans-acting elements in the isolated plurality of nuclei of step (e); (i) optionally determining, identifying, or sequencing the trans-acting elements in separated nuclei comprise a biotin acceptor peptide-biotin complex bound to the streptavidin-magnetic bead; and, (j) determining or calculating the relative fold difference each kind, type or sequence of the trans-acting elements determined, identified, or sequenced in steps (h) and step (i).
22. A platform or system or method to characterize the regulatory activity of gene variants, such as gene variants of trans-acting elements, in plant cells.
